Merck to buy Prometheus Biosciences for about $11 billion

admin-dominor April 16, 2023 Biotech and Pharmaceuticals, BUSINESS, business news, Health care industry, Merck & Co Inc, Prometheus Biosciences Inc

Merck has agreed to acquire Prometheus Biosciences for about $10.8 billion to bolster the company's presence in immunology, the companies said on Sunday.

Source link

Top Wall Street analysts say buy these stocks amid the latest macroeconomic uncertainty
Will Turkey’s elections finally spell the end of Recep Tayyip Erdoğan? – The Guardian

You May Also Like

Five wounded in Kyiv by largest drone attack yet on Ukraine, officials say

Germany’s Merkel era comes to an end as opposition parties strike deal

FDA panel recommends changing Covid shots to fight omicron this fall